Delivery Order SPE2DR25D3103-SPE2DR26F9K09
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Thrombin-JMI 5,000 unit vials. This competitively awarded, non-set-aside contract carries a ceiling value of $7,615.26 under a firm fixed-price delivery order arrangement, with an ultimate completion date of September 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Thrombin-JMI 5,000 Units Vials with a ceiling value of $1,451.48. This firm fixed price delivery order, which represents a child contract under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility and is scheduled for completion by November 28, 2025. The award was not designated as a set-aside contract,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,895.82 on August 26, 2025, for the supply of Thrombin-JMI 5,000 units vials, with an ultimate completion date of August 27, 2025. This firm fixed price contract is non-competitive and non-set-aside, with performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The award is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Thrombin-JMI 20,000 Units Pumps on December 1, 2025, with a ceiling value of $1,488.35 and an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a relatively small-value transaction within the broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,009.40 to AmerisourceBergen Drug Corp for Thrombin USP Bovine on December 12, 2025, with an ultimate completion date of December 15, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child contract under...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) as a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the delivery of 20,000 unit vials of Thrombin-JMI, a specialty pharmaceutical product, to support military healthcare programs. The award has a firm fixed price of $6,410.56 and a completion date of July 8, 2024. No set-aside designation was...
- This federal contract award is for the delivery of THROMBIN-JMI 20,000 UNIT VIALS to the Defense Logistics Agency (DLA), a major defense agency responsible for logistics support to the U.S. military. The contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, on September 22, 2023 with a ceiling value of $6,595.68 and a completion date of September 25, 2023. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation,...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of 20,000 units of Thrombin-JMI, a medical product used for surgical procedures. The award has a ceiling value of $6,656.64 and a firm fixed price, with an ultimate completion date of August 15, 2022. This contract is not designated as a set-aside. Amerisourcebergen holds a significant...
- This federal contract award, with ID SPE2DX15D2223|SPE2DX24F4GAN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,805.10 firm fixed price delivery order is for the supply of 5,000 unit vials of Thrombin-JMI, a specialty pharmaceutical product. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA...
- This contract award is for the delivery of 20,000 unit vials of THROMBIN-JMI to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a potential value of $2,061.15. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. This award is not associated...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9K09Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Thrombin-JMI 5,000 unit vials, with a ceiling value of $1,533.12. This is a firm fixed-price delivery order executed under a competitive, non-set-aside procurement. The contract is scheduled for ultimate completion by December 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value and runs through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling supply of a wide range of medications, specialty drugs, vaccines, and medical supplies to support Defense Health Agency and other government healthcare programs worldwide. As a child contract issued under this prime vehicle, the current delivery order for Thrombin-JMI represents a routine pharmaceutical supply transaction within AmerisourceBergen's established federal medical procurement portfolio with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/27/25 |